2 results
Approved WMOCompleted
The primary objective is to evaluate the pharmacokinetic (PK) parameters of JNJ-63623872 in combination with oseltamivir in elderly subjects (aged 65 to *85 years) compared to adults (aged 18 to *64 years) with influenza A infection.
Approved WMORecruiting
The purpose of this study is to demonstrate the efficacy of 9-valentextraintestinal pathogenic Escherichia coli vaccine (ExPEC9V) compared toplacebo in the prevention of the first invasive extraintestinal pathogenicEscherichia coli disease (IED)…